GlassScriptPhysician profile
Maryam Baikpour
NPI 1023512720
$694.81
in general payments reported to CMS, 2019-2025
13 companies · $21.06 in 2025
The $21.06 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.30 · 2020: $363 · 2021: $33.07 · 2022: $96.36 · 2023: $106 · 2024: $56.78 · 2025: $21.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $184.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $348.25 | 2020 | |
| Astellas Pharma US INC | $75.74 | 2023-2025 | Veozah |
| Merck Sharp & Dohme LLC | $51.37 | 2019-2021 | |
| Hologic Sales and Service, LLC | $40.08 | 2023-2024 | Localizer, Third Wave, Thinprep 2000 Processor |
| Organon LLC | $35.13 | 2022-2023 | Nexplanon |
| Mylan Pharmaceuticals INC. | $25.00 | 2022 | |
| Exact Sciences Corporation | $19.30 | 2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $18.23 | 2022 | |
| Therapeuticsmd, INC. | $18.07 | 2022 | |
| Abbvie INC. | $17.44 | 2023 | Lo Loestrin Fe, Orilissa |
| Amgen INC. | $15.94 | 2022 | |
| Lsi Solutions INC | $15.71 | 2023 | Fornisee |
| Astrazeneca Pharmaceuticals LP | $14.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maryam Baikpour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.